InsidersTradesSigma
Discover the complete record of transactions filed by Kalkofen Donald A., Chief Financial Officer. Director active across 1 companies, notably Protagonist Therapeutics, Inc. Aggregated, 2 filings have been logged. The latest transaction was disclosed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Donald A. Kalkofen is Chief Financial Officer at Protagonist Therapeutics, Inc. He is responsible for the financial management of the company, overseeing accounting and financial operations.